Skip to main content
Log in

A successful treatment for hepatocellular carcinoma with Osler–Rendu–Weber disease using radiofrequency ablation under laparoscopy

  • Case Report
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Hepatocellular carcinoma (HCC) can be difficult to diagnose and treat in patients with Osler–Rendu–Weber disease due to vascular malformation and regenerative nodular hyperplasia. In addition, percutaneous liver puncture should be avoided for the diagnosis and treatment as the procedure carries a high risk of bleeding. We herein report the successful treatment of HCC in a patient with Osler–Rendu–Weber disease using radiofrequency ablation (RFA) under laparoscopy. A 71-year-old man with Osler–Rendu–Weber disease was admitted to our hospital for the treatment of HCC. He also had chronic hepatitis C virus infection. The arterioportal shunts in the liver were detected by computed tomography (CT) and angiography. A tumor 20 mm in size was detected as a defected-lesion in the hepatic segment IV during the portal phase by CT. RFA under laparoscopy was performed for the curative treatment for HCC, with sufficient ablation obtained. Although the blood gushed out from the needle tract at the end of the procedure, complete hemostasis was achieved promptly using coagulation forceps. The post-operative course was favorable. Thus, laparoscopic RFA is a useful treatment modality for HCC in patients with Osler–Rendu–Weber disease, as a hemostasis device can be used with direct visualization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Garcia-Tsao G. Liver involvement in hereditary hemorrhagic telangiectasia (HHT). J Hepatol. 2007;46:499–507.

    Article  CAS  Google Scholar 

  2. Buscarini E, Danesino C, Olivieri C, et al. Liver involvement in hereditary haemorrhagic telangiectasia or Rendu-Osler-Weber disease. Dig Liver Dis. 2005;37:635–45.

    Article  CAS  Google Scholar 

  3. Wanless IR, Gryfe A. Nodular transformation of the liver in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med. 1986;110:331–5.

    CAS  PubMed  Google Scholar 

  4. Buscarini E, Danesino C, Plauchu H, et al. High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia. Ultrasound Med Biol. 2004;30:1089–97.

    Article  Google Scholar 

  5. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245–55.

    Article  Google Scholar 

  6. Lee JH, Lee YS, Kim PN, et al. Osler-Weber-Rendu disease presenting with hepatocellular carcinoma: radiologic and genetic findings. Korean J Hepatol. 2011;17:313–8.

    Article  Google Scholar 

  7. Blewitt RW, Brown CM, Wyatt JI. The pathology of acute hepatic disintegration in hereditary haemorrhagic telangiectasia. Histopathology. 2003;42:265–9.

    Article  CAS  Google Scholar 

  8. Scelzo C, Greco S, Bonanni L, et al. The role of liver transplantation in the treatment of hereditary hemorrhagic telangiectasia: a short literature review. Transplant Proc. 2007;39:2045–7.

    Article  CAS  Google Scholar 

  9. Gaujoux S, Bucau M, Ronot M, et al. Liver resection in patients with hepatic hereditary hemorrhagic telangiectasia. Dig Surg. 2013;30:410–4.

    Article  Google Scholar 

  10. Morimoto N, Isoda N, Takaoka Y, et al. Short-term results of laparoscopic radiofrequency ablation using a multipolar system for localized hepatocellular carcinoma. Liver Cancer. 2017;6:137–45.

    Article  Google Scholar 

  11. Casaccia M, Santori G, Bottino G, et al. Laparoscopic resection vs laparoscopic radiofrequency ablation for the treatment of small hepatocellular carcinomas: a single-center analysis. World J Gastroenterol. 2017;23:653–60.

    Article  Google Scholar 

  12. Santambrogio R, Podda M, Zuin M, et al. Safety and efficacy of laparoscopic radiofrequency ablation of hepatocellular carcinoma in patients with liver cirrhosis. Surg Endosc. 2003;17:1826–32.

    Article  CAS  Google Scholar 

  13. Cillo U, Vitale A, Dupuis D, et al. Laparoscopic ablation of hepatocellular carcinoma in cirrhotic patients unsuitable for liver resection or percutaneous treatment: a cohort study. PLoS One. 2013;8:e57249.

    Article  CAS  Google Scholar 

  14. Herbold T, Wahba R, Bangard C, et al. The laparoscopic approach for radiofrequency ablation of hepatocellular carcinoma–indication, technique and results. Langenbecks Arch Surg. 2013;398:47–53.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kouichi Miura.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Research involving human participants

All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

Informed consent was obtained from the patient for being included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takaoka, Y., Morimoto, N., Miura, K. et al. A successful treatment for hepatocellular carcinoma with Osler–Rendu–Weber disease using radiofrequency ablation under laparoscopy. Clin J Gastroenterol 11, 501–506 (2018). https://doi.org/10.1007/s12328-018-0877-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-018-0877-x

Keywords

Navigation